Jim Simons Surrozen, Inc. Transaction History

Renaissance Technologies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.44 - $0.89 $4,796 - $9,701	10,900 Added 9.59%	124,598 $61,000
Q2 2023 Aug 11, 2023	BUY	$0.55 - $0.72 $6,270 - $8,208	11,400 Added 11.14%	113,698 $63,000
Q1 2023 May 12, 2023	BUY	$0.56 - $1.32 $42,392 - $99,924	75,700 Added 284.61%	102,298 $62,000
Q4 2022 Feb 13, 2023	BUY	$0.42 - $2.01 $11,171 - $53,461	26,598 New	26,598 $15,000

4.52M

Ticker SRZN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,122,900
Market Cap $342M
Description
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, a...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.